Merck is making changes at the top of its Human Health unit, it announced Wednesday.
The Kenilworth-based company said in a news release that Michael T. Nally, its chief marketing officer, human health, will leave the company for another opportunity at the end of March. Frank Clyburn, chief commercial officer, human health, will become president, human health, and lead all commercial and marketing aspects of the unit.
“As our chief marketing officer, Mike has charted ambitious goals for our human health franchises, and has been instrumental in shaping our strategy and ensuring that Merck is well-positioned for a successful future,” Chairman and CEO Kenneth Frazier said in a prepared statement. “Mike’s unwavering commitment to Merck’s core values, coupled with his inclination to seek new and better ways to meet the needs of today’s patients, as well as those we hope to serve in the years ahead, have left an enduring mark on Merck, and he will be missed.”
Clyburn will take over the new role effective immediately, reporting to Frazier. Starting April 1, he will report to Robert M. Davis, who is becoming president of Merck on that date. Davis will take over the CEO role on July 1.
“I have tremendous respect for Frank’s strategic and operational excellence, and believe he is the perfect person to lead our ongoing success in human health,” Davis said in a statement. “Frank’s leadership in rapidly expanding our oncology footprint and accelerating the growth of that business is unparalleled in our industry, exceeded only by his relentless dedication to helping patients. I look forward to continuing to work with him as we advance Merck’s mission to save and improve lives.”
